第一单位：
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.;Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, K1A 0K9, Canada.
作者：
Jonathan M,Gobin [1]
;
Jun,Gao [2]
;
Veronica,Rey [3]
;
Juan,Tornín [4]
;
Gauri,Muradia [2]
;
Hala,Halabi [2]
;
Clara,Bueno [5]
;
Mercedes,Guerrero-Murillo [5]
;
Belen,Lopez-Millan [5]
;
Pablo,Menendez [6]
;
Michael,Rosu-Myles [1]
;
Rene,Rodriguez [7]
;
Jessie R,Lavoie [8]
作者单位：
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.;Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, K1A 0K9, Canada.
[1]
Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, K1A 0K9, Canada.
[2]
Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA) - Hospital Universitario Central de Asturias, Oviedo, 33011, Spain.;Instituto Universitario de Oncologia del Principado de Asturias, Oviedo, 33006, Spain.;Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain.
[3]
Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA) - Hospital Universitario Central de Asturias, Oviedo, 33011, Spain.;Instituto Universitario de Oncologia del Principado de Asturias, Oviedo, 33006, Spain.
[4]
Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
[5]
Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain.;Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.;Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCII) (RICORS, RD21/00170029), Madrid, Spain.;Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029), Barcelona, Spain.
[6]
Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA) - Hospital Universitario Central de Asturias, Oviedo, 33011, Spain. rene.rodriguez@ispasturias.es.;Instituto Universitario de Oncologia del Principado de Asturias, Oviedo, 33006, Spain. rene.rodriguez@ispasturias.es.;Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain. rene.rodriguez@ispasturias.es.
[7]
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada. jessie.lavoie@hc-sc.gc.ca.;Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON, K1A 0K9, Canada. jessie.lavoie@hc-sc.gc.ca.
[8]
DOI
10.1186/s12915-025-02498-z
PMID
41514266
发布时间
2026-01-09
换一批
